Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 5 minute read Pharma Industry News UK approves first-ever immunotherapy for type 1 diabetes — can teplizumab really delay onset by three years? MHRA approves teplizumab, the UK’s first immunotherapy for type 1 diabetes, delaying onset by three years. See how it could reshape care pathways. byPallavi MadhirajuAugust 14, 2025